Rosalind Advisors, Inc.

Investment Portfolio & 13F Holdings Analysis

About

Rosalind Advisors, Inc. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 34 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "TRVI",
  "SVRA",
  "NUVB",
  "MNMD",
  "PHVS",
  "REPL",
  "ABEO",
  "BFRI",
  "KALV",
  "MYO",
  "MDWD",
  null,
  "CYBN",
  null,
  "ACOG",
  null,
  "IDYA",
  null,
  null,
  "FENC",
  null,
  "COGT",
  "PROF",
  "CMPS",
  "DCTH",
  null,
  "KURA",
  "URGN",
  "VRNA",
  "VSTM",
  "VRDN",
  "XERS",
  "OPTN"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 34
Total Value: 205636842
Accession Number: 0001622627-25-000027
Form Type: 13F-HR
CIK: rosalind-advisors
Manager Name: Rosalind-Advisors

Data Enrichment

79% identified

27 identified7 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

34 positions • $205,636.842K total value

34 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 2

Sort by:

DELCATH SYSTEMS, INC.

DCTH|24661P807

Shares:2.9M

Value:$29.0M

Verastem, Inc.

VSTM|92337C203

Shares:2.6M

Value:$15.9M

Xeris Biopharma Holdings, Inc.

XERS|98422E103

Shares:2.5M

Value:$13.7M

MYOMO, INC.

MYO|62857J201

Shares:2.7M

Value:$13.0M

IDEAYA Biosciences, Inc.

IDYA|45166A102

Shares:700.0K

Value:$11.5M

FENNEC PHARMACEUTICALS INC.

FENC|31447P100

Shares:1.8M

Value:$10.9M

UroGen Pharma Ltd.

URGN|M96088105

Shares:950.0K

Value:$10.5M

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:1.2M

Value:$8.9M

ABEONA THERAPEUTICS INC.

ABEO|00289Y206

Shares:1.8M

Value:$8.6M

Replimune Group, Inc.

REPL|76029N106

Shares:850.0K

Value:$8.3M

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:595.0K

Value:$8.0M

MediWound Ltd.

MDWD|M68830112

Shares:506.9K

Value:$7.9M

Savara Inc

SVRA|805111101

Shares:2.7M

Value:$7.4M

Verona Pharma plc

VRNA|925050106

Shares:100.0K

Value:$6.3M

45779A846

Shares:2.3M

Value:$6.1M

CYBIN INC.

CYBN|23256X407

Shares:810.9K

Value:$5.1M

Nuvation Bio Inc.

NUVB|67080N101

Shares:2.5M

Value:$4.3M

Profound Medical Corp.

PROF|74319B502

Shares:692.2K

Value:$4.0M

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:612.9K

Value:$3.9M

Pharvaris N.V.

PHVS|N69605108

Shares:223.6K

Value:$3.5M

Instrument	Shares		Other Manager	Value
DELCATH SYSTEMS, INC.(DCTHcusip24661P807)	2.9M	QoQ +9.43% (-250.0K) YoY +179.19% (+1.9M)	All Managers (Combined)	$29.0M	QoQ -9.10% (-$2.9M) YoY +485.32% (+$24.0M)
Verastem, Inc.(VSTMcusip92337C203)	2.6M	QoQ +193.83% (+1.7M) YoY NEW(+2.6M)	All Managers (Combined)	$15.9M	QoQ +242.71% (+$11.3M) YoY NEW(+$15.9M)
Xeris Biopharma Holdings, Inc.(XERScusip98422E103)	2.5M	QoQ -19.61% (-609.0K) YoY -11.49% (-324.2K)	All Managers (Combined)	$13.7M	QoQ +30.18% (-$3.2M) YoY +119.86% (-$7.5M)
MYOMO, INC.(MYOcusip62857J201)	2.7M	QoQ -9.84% (-295.3K) YoY +10.45% (+255.9K)	All Managers (Combined)	$13.0M	QoQ -32.66% (-$6.3M) YoY +62.47% (+$5.0M)
IDEAYA Biosciences, Inc.(IDYAcusip45166A102)	700.0K	QoQ NEW(+700.0K) YoY NEW(+700.0K)	All Managers (Combined)	$11.5M	QoQ NEW(+$11.5M) YoY NEW(+$11.5M)
FENNEC PHARMACEUTICALS INC.(FENCcusip31447P100)	1.8M	QoQ +41.50% (+523.0K) YoY NEW(+1.8M)	All Managers (Combined)	$10.9M	QoQ +36.35% (+$2.9M) YoY NEW(+$10.9M)
UroGen Pharma Ltd.(URGNcusipM96088105)	950.0K	QoQ +9.19% (+80.0K) YoY NEW(+950.0K)	All Managers (Combined)	$10.5M	QoQ +13.39% (+$1.2M) YoY NEW(+$10.5M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	1.2M	QoQ +7.97% (-90.0K) YoY NEW(+1.2M)	All Managers (Combined)	$8.9M	QoQ -7.32% (-$706.0K) YoY NEW(+$8.9M)
ABEONA THERAPEUTICS INC.(ABEOcusip00289Y206)	1.8M	QoQ +0.02% (-427) YoY NEW(+1.8M)	All Managers (Combined)	$8.6M	QoQ -14.52% (-$1.5M) YoY NEW(+$8.6M)
Replimune Group, Inc.(REPLcusip76029N106)	850.0K	QoQ +226.92% (+590.0K) YoY NEW(+850.0K)	All Managers (Combined)	$8.3M	QoQ +163.21% (+$5.1M) YoY NEW(+$8.3M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	595.0K	QoQ NEW(+595.0K) YoY +98.33% (+295.0K)	All Managers (Combined)	$8.0M	QoQ NEW(+$8.0M) YoY +52.68% (+$2.8M)
MediWound Ltd.(MDWDcusipM68830112)	506.9K	QoQ -19.29% (-121.2K) YoY +4.30% (+20.9K)	All Managers (Combined)	$7.9M	QoQ -29.62% (-$3.3M) YoY +13.59% (+$941.6K)
Savara Inc(SVRAcusip805111101)	2.7M	QoQ 0.00% (-0) YoY NEW(+2.7M)	All Managers (Combined)	$7.4M	QoQ -9.77% (-$796.5K) YoY NEW(+$7.4M)
Verona Pharma plc(VRNAcusip925050106)	100.0K	QoQ -33.33% (-50.0K) YoY -60.00% (-150.0K)	All Managers (Combined)	$6.3M	QoQ -8.85% (-$617.0K) YoY +57.83% (-$2.3M)
(cusip45779A846)✕	2.3M	QoQ -8.84% (-220.8K) YoY +231.60% (+1.6M)	All Managers (Combined)	$6.1M	QoQ -6.76% (-$444.2K) YoY +276.35% (+$4.5M)
CYBIN INC.(CYBNcusip23256X407)	810.9K	QoQ 0.00% (-0) YoY NEW(+810.9K)	All Managers (Combined)	$5.1M	QoQ -28.11% (-$2.0M) YoY NEW(+$5.1M)
Nuvation Bio Inc.(NUVBcusip67080N101)	2.5M	QoQ NEW(+2.5M) YoY NEW(+2.5M)	All Managers (Combined)	$4.3M	QoQ NEW(+$4.3M) YoY NEW(+$4.3M)
Profound Medical Corp.(PROFcusip74319B502)	692.2K	QoQ 0.00% (-0) YoY +29.78% (-158.9K)	All Managers (Combined)	$4.0M	QoQ -22.50% (-$1.2M) YoY -11.44% (-$520.8K)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	612.9K	QoQ -42.31% (-449.6K) YoY -33.81% (-313.1K)	All Managers (Combined)	$3.9M	QoQ -11.93% (-$522.4K) YoY +20.67% (-$660.4K)
Pharvaris N.V.(PHVScusipN69605108)	223.6K	QoQ NEW(+223.6K) YoY NEW(+223.6K)	All Managers (Combined)	$3.5M	QoQ NEW(+$3.5M) YoY NEW(+$3.5M)